Skip to content

Compare outcome of direct superior approach versus posterior lateral approach THA: a randomized controlled trial

Compare outcome of direct superior approach versus posterior lateral approach THA: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041186
Enrollment
Unknown
Registered
2020-12-21
Start date
2020-12-28
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip arthropathy

Interventions

DSA:DSA approach THA
PL:PL approach THA

Sponsors

IRB of Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) According to the patient's history, physical examination, imaging examination, diagnosed as hip joint disease, including femoral head necrosis, type I acetabular dysplasia, hip osteoarthritis, etc., patients who need unilateral total hip arthroplasty for the first time; (2) Aged 20-60 years, regardless of gender; (3) Quadriceps muscle strength of the affected side 4-5; (4) Signing informed consent for operation.

Exclusion criteria

Exclusion criteria: (1) Patients with severe mental disease, systemic disease or other basic diseases and poor local skin conditions who are unable to accept total hip replacement surgery; (2) Poor mental and conscious state, unable to cooperate with researchers; (3) poor compliance, not cooperating with or refusing participants, and missing during the interview; (4) patients with severe osteoporosis, severe pelvic deformity, and hip joint trauma; (5) patients with previous hip surgery and internal fixation; (6) stiff hip, ankylosing spondylitis, dysplasia of hip above type II and infectious arthritis.

Design outcomes

Primary

MeasureTime frame
hip Harris score;

Secondary

MeasureTime frame
wound incision length;operation time;estimated total blood loss;VAS score;complication;

Countries

China

Contacts

Public ContactBin Feng

Orthopaedic Department, Peking Union Medical College Hospital

pumcfeng@163.com+86 13810487811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026